TNEUROPHARMA
TNeuroPharma develops a therapeutic-based technology focusing on the T-cell contribution in tracking and treating neurodegenerative disease. Its technology helps to target the dysfunctional t-cells which helps in detecting Alzheimer's disease through the use of blood samples, enabling patients to detect and treat the disease at the early stage and to prevent any complications in the future. The company was founded in 2018 and is based in Albuquerque, New Mexico.
TNEUROPHARMA
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2018-01-01
Address:
Albuquerque, New Mexico, United States
Country:
United States
Website Url:
http://www.tneuropharma.com
Status:
Active
Contact:
575.644.1361
Email Addresses:
[email protected]
Total Funding:
25 K USD
Investors List
New Mexico Economic Development Department
New Mexico Economic Development Department investment in Grant - TNeuroPharma
Arrowhead Innovation Fund
Arrowhead Innovation Fund investment in Seed Round - TNeuroPharma
Official Site Inspections
http://www.tneuropharma.com
- Host name: cloudproxy10090.sucuri.net
- IP address: 192.124.249.90
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "TNeuroPharma"
TNeuroPharma - Crunchbase Company Profile & Funding
TNeuroPharma develops a therapeutic-based technology focusing on the T-cell contribution in tracking and treating neurodegenerative disease. Its technology helps to target the …See details»
About T-Neuro Pharma - T-Neuro Pharma
Most importantly, we believe that effective treatments for Alzheimer’s disease and other neurodegenerative disorders are within our reach. And our goal is to assist and support …See details»
TNeuroPharma Company Profile 2024: Valuation, Funding
Oct 29, 2019 www.tneuropharma.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 1451 Innovation Parkway South East; Suite …See details»
TNeuroPharma - The Org
TNeuroPharma develops a therapeutic-based technology focusing on the T-cell contribution in tracking and treating neurodegenerative disease. Industries Health Care , TherapeuticsSee details»
TNeuroPharma Company Profile | Management and Employees …
TNeuroPharma Profile and History . Doctors and Scientists agree that treatments for Alzheimers Disease will be most effective in the earliest stages of the disease. But currently, Alzheimers …See details»
T-neuropharma - Products, Competitors, Financials, Employees ...
Tneuropharma.com. Overview & Products; About T-neuropharma. T-Neuro Pharma focuses on developing biomarkers for the detection of Alzheimer's disease in the pharmaceutical sector. …See details»
TNeuroPharma - Funding, Financials, Valuation & Investors
TNeuroPharma develops a therapeutic-based technology focusing on the T-cell contribution in tracking and treating neurodegenerative disease. Search Crunchbase. ... How much funding …See details»
TNeuroPharma - Crunchbase
TNeuroPharma develops a therapeutic-based technology focusing on the T-cell contribution in tracking and treating neurodegenerative disease.See details»
TNeuroPharma - Drug pipelines, Patents, Clinical trials - Synapse
Explore TNeuroPharma with its drug pipeline, therapeutic area, technology platform, .See details»
TNeuroPharma - Overview, News & Similar companies - ZoomInfo
TNeuroPharma. Business Services · New Mexico, United States · <25 Employees. View Company Info for Free. About. Headquarters 1451 Innovation Pkwy SE Ste 600, Albuquerque, …See details»
TNeuroPharma - Company Profile - Tracxn
TNeuroPharma - Developer of a diagnostic test to detect Alzheimer’s disease. Raised a total funding of $1.2M over 1 round from 1 investor. TNeuroPharma has 48 competitors.See details»
T-Neuro Pharma | F6S
Tneuropharma.com. About T-Neuro Pharma. We are an early stage company that is developing an Alzheimer's biomarker/therapeutic combination. We are not taking the typical approach of …See details»
Contact - T-Neuro Pharma
Get In Touch Contact us today to learn more about our technology and product innovation, and see how you can benefit from working with us. Name First Last Email Your Message* …See details»
T-Neuro Pharma Welcomes Renowned Alzheimer's Researcher Dr.
Nov 7, 2024 T-Neuro Pharma, a leading biotechnology company dedicated to developing innovative therapies for neurodegenerative diseases, announced today the appointment of Dr. …See details»
TNeuroPharma - Tech Stack, Apps, Patents & Trademarks
TNeuroPharma is actively using 30 technologies for its website, according to BuiltWith. These include Viewport Meta , IPhone / Mobile Compatible , and SPF . Website Tech Stack by BuiltWithSee details»
Albuquerque-based TNeuroPharma lands patent for its …
Nov 7, 2022 The approval is for a "method patent," said Kristina Trujillo, TNeuroPharma's CEO. It's licensed exclusively to TNeuroPharma for the company's method of detecting T-cells in …See details»
T-Neuro Pharma Welcomes Renowned Alzheimer's Researcher Dr.
T-Neuro Pharma, a leading biotechnology company dedicated to developing innovative therapies for neurodegenerative diseases, announced today the appointment of Dr. Jeffrey Cummings, …See details»
Technology - T-Neuro Pharma
Targeting T Cells T-Neuro Pharma was created to provide science-based solutions in the continuing quest to find a treatment for one of today’s most critical public health crises: …See details»
T-Neuro Pharma Announces Publication of Groundbreaking …
Jul 16, 2024 ALBUQUERQUE, New Mexico — T-Neuro Pharma, a leading biotechnology company dedicated to developing innovative diagnostics and therapeutics for …See details»